Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stargardt Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05674058
What this trial is testing

Function and Imaging Assessments for G1961E-associated Stargardt Disease

Who this might be right for
Stargardt DiseaseStargardt Disease 1Fundus Flavimaculatus+2 more
University Hospital, Basel, Switzerland 20
Not applicableLooking for participantsNCT07425574
What this trial is testing

Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Who this might be right for
Stargardt DiseaseStargardt Macular DystrophyStargardt-like Macular Dystrophy
Astellas Pharma Global Development, Inc. 90
Not applicableLooking for participantsNCT06435000
What this trial is testing

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

Who this might be right for
StargardtStargardt's DiseaseStargardt Disease+1 more
Splice Bio 75
Not applicableNot Yet RecruitingNCT07265895
What this trial is testing

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

Who this might be right for
Retinal DegenerationsRetinitis Pigmentosa (RP)Stargardt Disease
IRCCS San Raffaele 200
Not applicableActive Not RecruitingNCT06591806
What this trial is testing

An Observational Study in Children and Adults With Stargardt Disease

Who this might be right for
Stargardt Disease
AAVantgarde Bio Srl 80
Not applicableStudy completedNCT02410122
What this trial is testing

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy

Who this might be right for
Stargardt Disease
Johns Hopkins University 15
Testing effectiveness (Phase 2)Study completedNCT02903576
What this trial is testing

Stem Cell Therapy for Outer Retinal Degenerations

Who this might be right for
Age Related Macular DegenerationStargardt's DiseaseExudative Age-related Macular Degeneration
Federal University of São Paulo 15
Not applicableStudy completedNCT05904444
What this trial is testing

The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Who this might be right for
Macular DegenerationLow VisionStargardt Disease
Aier Eye Hospital, Guangzhou 29
Testing effectiveness (Phase 2)Ended earlyNCT01367444
What this trial is testing

Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration

Who this might be right for
Stargardt's Disease
Sanofi 27
Large-scale testing (Phase 3)Study completedNCT05244304
What this trial is testing

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Who this might be right for
Stargardt Disease 1
Belite Bio, Inc 104
Not applicableLooking for participantsNCT01145196
What this trial is testing

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Who this might be right for
GenotypeRetinal Disease
National Eye Institute (NEI) 320
Very early researchLooking for participantsNCT07063251
What this trial is testing

An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

Who this might be right for
Stargardt Disease Type 1 (STGD1)
HuidaGene Therapeutics Co., Ltd. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06942572
What this trial is testing

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy
Splice Bio 57
Not applicableEnded earlyNCT02875704
What this trial is testing

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Who this might be right for
Stargardt DiseaseDiabetic RetinopathyMacular Degeneration (Age Related)
Johns Hopkins University 77
Not applicableLooking for participantsNCT07266584
What this trial is testing

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Who this might be right for
Stargardt DiseaseRetinitis Pigmentosa (RP)Inherited Retinal Degeneration
Science Corporation 5
Testing effectiveness (Phase 2)Looking for participantsNCT07439887
What this trial is testing

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Who this might be right for
Stargardt Disease
Ray Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01469832
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 12
Not applicableNot Yet RecruitingNCT07298174
What this trial is testing

Wide Field OCTA in Ocular Diseases

Who this might be right for
Age - Related Macular Degeneration (AMD)Diabetic Macular EdemaDiabetic Retinopathy+13 more
IRCCS San Raffaele 200
Early research (Phase 1)Study completedNCT00060749
What this trial is testing

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 22
Testing effectiveness (Phase 2)Study completedNCT05266014
What this trial is testing

This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease

Who this might be right for
Stargardt Disease
RBP4 Pty Ltd 13
Next Page